Dr. Bonn-Miller has over 20 years of experience in cannabinoid research. He previously served as Vice-President of Human and Animal Research at Canopy Growth Corporation and held roles at Zynerba Pharmaceuticals, the University of Pennsylvania, and the Department of Veterans Affairs. He has published over 150 research papers and co-authored three patents related to CBD's use in treating psychological illnesses. Dr. Bonn-Miller also reviews medical literature on cannabinoids, addiction, and behavioral psychology and serves on the editorial boards of several scientific journals. Dr. Bonn-Miller has guided the US Congress regarding significant CBD safety studies through an RFI process through ONE HEMP.